Board Meetings for TORNTPHARM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| TORNTPHARM | Torrent Pharmaceuticals Limited | 15 May 2009 | Audited Financial Results and Dividend | To consider, inter alia, the Audited Financial Results of the Company for the year ended on March 31, 2009 and recommendation of dividend for the financial year 2008-09. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 28 Jan 2009 | Audited Financial Results / Unaudited Financial Results | To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on December 31, 2008. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 24 Oct 2008 | Audited Financial Results / Unaudited Financial Results | To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2008. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 06 May 2008 | Audited Financial Results and Dividend | To consider, inter alia, the Audited Financial Results of the Company for the year ended on March 31, 2008 and dividend for 2007-08. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 31 Jan 2008 | Audited Financial Results / Unaudited Financial Results | To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on December 31, 2007. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 30 Oct 2007 | Audited Financial Results / Unaudited Financial Results | To consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on September 30, 2007. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 31 Jul 2007 | Audited Financial Results | To consider, inter alia, Audited Financial Results of the Company for the quarter ended on June 30, 2007. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 23 May 2007 | Audited Financial Results | To consider, interalia, the Audited Financial Results of the Company for the year ended on March 31, 2007. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 17 Mar 2007 | Interim Dividend/Record date/Others | Inter alia, to consider declaration of Interim Dividend for the year 2006-07. Further, the Company has fixed March 26, 2007 as the Record date for the purpose of payment of said Interim Dividend, if declared and the payout of the said Interim Dividend if declared will be on & from March 30, 2007. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 24 Jan 2007 | Audited Financial Results | To consider, inter alia, Audited Financial Results of the Company for the quarter ended on December 31, 2006. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 28 Oct 2006 | Audited Financial Results | To consider, inter alia, Audited Financial Results of the Company for the quarter and half year ended on September 30, 2006. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 21 Jul 2006 | Audited Financial Results | To consider, inter alia, Audited Financial Results of the Company for the quarter ended on June 30,2006. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 23 May 2006 | Audited Accounts and Dividend | To Consider, Interalia, the Audited Financial Results of the company for the year ended on March 31, 2006 and dividend for the year 2005-06, if any. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 25 Jan 2006 | Audited Financial Results | To consider, inter alia, Audited Financial Results of the Company for the quarter ended on December 31, 2005. | - |
| TORNTPHARM | Torrent Pharmaceuticals Limited | 15 Dec 2005 | Bonus/Sub-division | To consider, inter-alia, sub-division of the equity shares of the company and issuance of bonus shares to the equity shareholders of the company. | - |